Skip to content
Research Study for Relapse or Intolerance to Treatment for Moderate to Severe UC-Palm Harbor, FL
avatar
agaresearch posted:
Moderate to Severe Ulcerative Colitis You may qualify to participate in a clinical research study with an investigational drug for individuals with Moderate to Severe Ulcerative Colitis.
· At least 18 years of age
· Have a documented diagnosis of moderate to severe Ulcerative Colitis = 4 months prior
· Have failed or be intolerant of at least one of the following treatments for UC:
o Oral corticosteroids
o Azathioprine or 6-mercaptopurine (6-MP)
o Anti-TNF therapy: infliximab or adalimumab
· If taking the one of the following medication, are on a stable dose:
o Oral 5-ASA or sulfasalazine stable dose for at least 4 weeks prior to start of study drug and during study period
o Oral corticosteroids (prednisone equivalent up to 25mg/day; budesonide up to 9 mg/day) stable dose for at least 2 weeks prior to start of study drug and during study period
o Chronic treatment for ulcerative colitis with antibiotics (eg, metronidazole, rifaximim) stable dose for at least 2 weeks prior to start of study drug and during study period.
Qualified participants will receive at no cost:
· Study-related medical exams and follow-ups
· Laboratory testing
· Study medication
For more information, please contact:
Joanne Root, CCRC
Advanced Gastroenterology Associates, LLC
Research Department
34041 US Highway 19, North, Suite A
Palm Harbor, FL 34684
727-216-0768 Direct Line
727-786-7521 Fax
research@advancedgastro.com email
All medical information is strictly confidential
Reply


Spotlight: Member Stories

I have had crohns since 1998 going to restroom all the time or, having "accidents" all the time really sucks . my daughter has an auto immun...More

Helpful Tips

Prednisone short term versus long term use!
Predinisone can be a very helpful anti-inflammatory drug when used over the shortest term use that is effective. Predisone and other ... More
Was this Helpful?
3 of 3 found this helpful